One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

“Viral and bacterial infectious causes of common dementias have been proposed, supported by epidemiological data linking ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Two types of drugs have been approved by the FDA to treat Alzheimer's disease: Cholinesterase inhibitors and memantine. Both change the way the brain interacts with important chemicals that are ...